开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
US Vice President Vance said traffic through the Strait of Hormuz has increased and that the Iran agreement includes a two-step verification process.
2026-06-15
US Vice President Vance said traffic through the Strait of Hormuz has increased and that the Iran agreement includes a two-step verification process.
返回
其他消息
2026-06-15
Novo Nordisk (NVO.N) said the world’s first and currently only approved weekly basal insulin/GLP‑1 receptor agonist, icodec/semaglutide injection, has launched in China. The product is approved for adults with type 2 diabetes whose blood glucose remains uncontrolled on basal insulin or a GLP‑1 RA, to be used with oral glucose‑lowering drugs alongside diet and exercise.
Novo Nordisk (NVO.N) said the world’s first and currently only approved weekly basal insulin/GLP‑1 receptor agonist, icodec/semaglutide injection, has launched in China. The product is approved for adults with type 2 diabetes whose blood glucose remains uncontrolled on basal insulin or a GLP‑1 RA, to be used with oral glucose‑lowering drugs alongside diet and exercise.
2026-06-15
欧盟委员会主席冯德莱恩:我们必须实现多元化,摆脱对霍尔木兹海峡这一瓶颈的依赖,开发替代方案。
欧盟委员会主席冯德莱恩:我们必须实现多元化,摆脱对霍尔木兹海峡这一瓶颈的依赖,开发替代方案。
Chat with us
, powered by
LiveChat